1. Field of the Invention
The present invention relates to methods and systems for processing samples using microfluidic systems. More particularly, the invention relates to moving fluid samples within a microfluidic system. Description of the Related Art
2. Background
Microfluidic devices are typically formed of substrates (made of silicon, glass, ceramic, plastic and/or quartz) which include a network of micro-channels through which fluid flows under the control of a propulsion mechanism. The micro channels typically have at least one dimension which is on the order of nanometers to hundreds of microns.
Microfluidic devices process minute amounts of fluid sample to determine the physical and chemical properties of the sample. Microfluidic devices offer several advantages over a traditional macro-scale instrumentation. For example, in general, they require substantially smaller fluid samples, use far less reagent, and process these fluids at substantially greater speeds than macro-scale equipment.
Electric fields are used as a propulsion mechanism for some microfluidic devices. In such devices, a high voltage, on the order of kilovolts, is applied across electrodes within the device to thereby generate an electric field in the micro channels. The field imposes a force on ions within the fluid, thereby propelling the ions through the micro channel. The fluid itself may also be propelled by the motion of ions moving within the fluid.
Gas pressure is also used to propel fluid through micro channels. In some devices, a source of pressurized gas, external to the microfluidic device, is connected to the microfluidic device to supply a gas pressure, which propels the fluid. Gas pressure may also be generated by a heated chamber within the microfluidic device itself to propagate fluid within a micro channel.
In general, the invention relates to a system and method for moving samples, such as fluids, within a microfluidic system. In one aspect, the invention relates to the use of a plurality of gas actuators for applying pressure at different locations within the microfluidic system to thereby supply force for moving samples. For example, in one embodiment, a first gas actuator provides a gas pressure sufficient to move a first sample from a first location to a second location of the microfluidic device. A second gas actuator provides a gas pressure to move another sample from a third location to a fourth location of the microfluidic device.
In another example, a plurality of gas actuators cooperate to move the same fluid sample. A first gas actuator provides a gas pressure sufficient to move the microdroplet between first and second processing zones of the microfluidic device, and a second gas actuator provides a gas pressure to move the microdroplet to a third processing zone.
In preferred embodiments, the plurality of actuators are integral with a microfluidic network through which the microfluidic samples flow. For example, a plurality of gas actuators can be fabricated in the same substrate which forms the microfluidic network. One such gas actuator is coupled to the network at a first location for providing gas pressure to move a microfluidic sample within the network. Another gas actuator is coupled to the network at a second location for providing gas pressure to further move at least a portion of the microfluidic sample within the network.
In other aspect, the invention relates to the use of valves with the plurality of actuators. For example, in one embodiment, a valve is coupled to a microfluidic network so that, when the valve is closed, it substantially isolates the second gas actuator from the first gas actuator. Such valves can control the direction of the propulsive force of the actuatators by preventing the expanding gas from traveling in certain directions, while permitting it to expand in the desired direction. They also extend the range over which an actuator can propel a microdroplet, by preventing the gas from dissipating in certain in areas upstream from the microdroplet.
The present invention is described below in reference to the following drawings, in which:
a shows a top view of a microdroplet preparation zone of the microfluidic device of
b shows cross sectional view of the microdroplet preparation zone of
a shows a top view of a microdroplet preparation zone of the microfluidic device of
b shows a cross sectional side view of the microdroplet preparation zone of
a-10c show cross sectional side views of a capillary assisted fluid barrier of the present invention;
a-11c show top views of a fluid barrier comprising a vent;
a and 12b show top views of the lysing module of the microfluidic device of
a and 13b show a second embodiment of a lysing module of the invention;
a-15c show a second microdroplet preparation module of the invention.
The present invention relates to microfluidic systems and methods for processing materials, such as samples and reagents. More specifically, the invention relates to microfluidic systems and methods for moving fluids within a microfluidic system. In the embodiment described below, the fluid includes particles which tend to move with the fluid. The fluid component of the particle-containing fluid is a gas or, preferably, a liquid. The particles of the particle-containing fluid are preferably whole cells, such as bacterial cells or cells of an animal, such as a human. However, they may include intracellular material from such cells. For example, a system of the invention may be used to process a sample of bacterial cells to determine whether the bacteria are pathogenic.
A. System Overview
Computer 127 preferably performs high level functions, such as supplying a user interface that allows a user to select desired operations, notifying the DAQ 126 as to the selected operations, and displaying for the user the results of such operations. These operations include, for example, subjecting a sample to process steps within the various process zones of the microfluidic device. The computer 127 may be a portable computer to facilitate transport of the microfluidic system.
Computer 127 is connected to DAQ 126 via connection 128, which provides data I/O, power, ground, reset, and other functional connectivity. Alternatively, a wireless link 132 between the computer 127 and the DAQ 126 may be provided for data and control signal exchange via wireless elements 132(a) and 132(b). Where the data link is a wireless link, for example, the DAQ 126 may have separate power source, such as a battery.
In general, DAQ 126 controls the operation of microfluidic device 110 in accordance with the high level instructions received from computer 127. More specifically, to implement a desired operation requested by computer 127, DAQ 126 supplies the appropriate electrical control signals to cartridge 120 via contacts 125.
Cartridge 120 provides electrical and optical connections 121 for electrical and optical signals between the DAQ 126 and the microfluidic substrate 110, thereby allowing DAQ 126 to control the operation of the substrate.
The chip carrier cartridge 120 is shown being inserted into (or removed from) an interface hardware receptacle of the DAQ 126 having electrical and optical contacts 125 standardized to mate with a corresponding contacts 121 of the chip carrier cartridge 120. Most contacts are for electrical signals, while certain ones are for optical signals (IR, visible, UV, etc.) in the case of optically-monitored or optically-excited microfluidic processors. Alternatively (not shown), the entire DAQ 126 may be a single ASIC chip that is incorporated into the Chip Carrier Cartridge 120, wherein contacts 121,125 would become conductive pathways on a printed circuit board.
B. Microfluidic Device
The upper substrate 130 depicted in
The microfluidic network includes a plurality of zones. The number of zones, as well as the overall topology of the microfluidic network, will depend upon the particular application which the microfluidic device is designed to perform. The zones of the microfluidic device may have any cross-sectional shape, such as generally arcuate or generally polygonal. For example, a zone may include channels, chambers or other substantially enclosed spaces. By “substantially enclosed” it is meant that materials enter or exit the zones only through predetermined pathways. Examples of such pathways include channels, microchannels and the like, which interconnect the various zones. The zones preferably have at least one micro-scale dimension, such as less than about 250 μm or, more preferably, less than about 75 μm.
The channels and chambers of the microfluidic network are etched in the bottom surface 136 of the upper substrate 130 using known photolithographic techniques. More specifically, transparent templates or masks containing opaque designs are used to photo-define objects on the surface of the substrate. The patterns on the templates are generated with computer-aided-design programs and can delineate structures with line-widths of less than one micron. Once a template is generated, it can be used almost indefinitely to produce identical replicate structures. Consequently, even extremely complex microfluidic networks can be reproduced in mass quantities and at low incremental unit cost. Alternatively, if a plastic material is used, the upper substrate may be formed using injection molding techniques, wherein the micro-channels are formed during the molding process.
The lower substrate 132 may include a glass base 138 and an oxide layer 140. Within oxide layer 140, resistive heaters 142 and electric leads 144 are formed using photo-lithographic techniques. The leads 144 connect to terminals 146 which are exposed at the edge of the substrate to penult electrical connection to cartridge 120, thereby permitting DAQ 126 to control the heaters. More specifically, to activate a heater 142, DAQ 126 applies a voltage across a pair of terminals 146 (via cartridge 120) to supply current through leads 146 and heater 142, thereby heating the resistive heater element 142.
Metal heater elements 142 are positioned so that, when the upper and lower substrates are bonded together, the heaters reside directly beneath certain regions of the fluid network of the upper substrate so as to be able to heat the contents of these regions. The silicon oxide layer 140 prevents the heating elements 142 from directly contacting with material in the microfluidic network.
The oxide layer 140, heating elements 142, and resistive leads 144 are fabricated using well-known photolithographic techniques, such as those used to etch microfluidic network.
The substrate also includes process modules 156, 158, 160, 166 and 162 for processing the sample and reagent materials. Within these process modules, a sample may be subjected to various physical and chemical process steps. For example, enrichment module 156 prepares a fluid sample having a relatively high concentration of cell particles, lysing module 160 releases intracellular material from the cell particles, and mixing module 166 mixes the resultant sample with certain reagents. As another example, an amplification process module 162 may be used to amplify and detect minute quantities of DNA within a sample.
Various modules of microfluidic device 110 are connected, such as by channels 164, to allow materials to be moved from one location to another within the device 110. Actuators 168, 170, 172 associated with the microfluidic device provide a motive force, such as a gas pressure, to move the sample and reagent material along the channels and zones. For example, a first actuator 168 moves material downstream from process module 156 to process module 158. Upon completion of processing within process module 158, a second actuator 170 moves material downstream to mixing process module 160. Subsequently, actuator 170 or an additional actuator moves the material to mixing module 166, where the material mixes with a reagent moved by actuator 172. Finally, actuator 172, or another actuator, moves the mixed material to module 162.
Because each actuator is preferably responsible for moving materials within only a subset of the modules of device 110, sample materials can be controlled more precisely than if a single actuator were responsible for moving material throughout the entire device. The various functional elements, of microfluidic device 110, including the actuators, are preferably under computer control to allow automatic sample processing and analysis.
C. Multiple Actuators
The various actuators of microfluidic device 110 cooperate to move material between different locations of microfluidic device 110. For example, actuator 168 moves material, such as an enriched sample, between an enrichment zone 931 and a microdroplet preparation module 158. Actuator 170 prepares a microdroplet from the enriched sample and, in so doing, moves the microdroplet to a lysing zone 950. Actuator 170 is used to move material from the lysing zone 950 to mixing module 166. It should be noted, however, that another actuator may be disposed intermediate between lysing zone 950 and microdroplet preparation zone to move the lysed sample downstream to the mixing module 166.
Actuators of device 110 may also cooperate in moving two amounts of material simultaneously. For example, as described above, actuator 172 and actuator 170 cooperate to mix reagent and lysed microdroplets. Such cooperative actuators can be controlled independently of one another to ensure proper mixing. For example, if one material is known to be more viscous, the motive force moving that material can be increased independently of the motive force moving the other material.
The multiple actuators and modules of microfluidic device 110 are preferably operatively connectable and isolatable by the valves of microfluidic device. For example, a closed state of either of valves 915, 216 operatively isolates microdroplet preparation module 170 from enrichment module 156. Thus, one or more actuators can be used to move materials between predetermined locations within microfluidic device 110, without perturbing or contacting material present in an operatively isolated module. The ability to operatively connect and isolate desired modules is advantageous in microfluidic devices having many process functions. Further, these valves also control the direction of the propulsive force of the actuatators by preventing the expanding gas from traveling in certain directions, while permitting it to expand in the desired direction. This also extends the range over which an actuator can propel a microdroplet, by preventing the gas from dissipating in certain in areas upstream from the microdroplet.
The following demonstrates the cooperative operation of such multiple actuators in an example embodiment having a plurality of processing modules, namely an enrichment zone 915, a microdroplet preparation module 158, a cell lysing module 160, a mixing module 166 and a DNA manipulation module 167.
1. Enrichment Module
a. Structure of Enrichment Module.
Referring to
The enrichment module includes an enrichment zone 931 (
The flow through member is also connected to the sample input module 150 via the sample introduction channel 929 to allow fluid to flow into the enrichment zone. Valve 913 is connected to this sample introduction channel to control the in-flow and out-flow of fluid from the input port.
Space 400 is formed during the fabrication of upper substrate 130. As discussed above, microfluidic features, such as zones and channels, are fabricated at surface 136 of substrate 130. Space 400, however, is fabricated at a surface 137, which is preferably disposed on the other side of substrate 130, opposite surface 136. Thus, even when surface 136 is mated with lower substrate 132, fluid can exit enrichment zone 931 via flow through member 900.
Flow through member 900 and absorbent material 402 do not require adhesives or other fasteners for positioning within substrate 130. Rather flow through member 900 and absorbent material 402 may be formed of a shape and size that substantially corresponds to space 400. Friction then holds flow through member 900 and absorbent material 402 in place once they are positioned in space 400. Any residual gap at locations 404 between flow through member 900 and substrate 130 should be small enough to prevent particles from exiting enrichment zone 931 through the gap 404. Naturally, adhesive or other fastening means may be used to secure flow through member 900 or absorbent material 402.
In an alternative embodiment, a flow through member is formed integrally with a substrate by using microfabrication techniques, such as chemical etching, that introduce pores or other pathways into the substrate. The pores provide fluid passage between enrichment zone 931 and an outer portion of the substrate.
b. Operation of Enrichment Module
To enrich a sample, the device 901 operates as follows. Referring to
Thus, flow through member 900 provides the only path for fluid to exit the enrichment channel. Fluid passes through surface 941 and exits enrichment zone 931 via second surface 943, while particles accumulate within the zone. Enrichment zone 931 can therefore receive a volume of fluid that is larger than the volume of the enrichment chamber 931. Thus, as fluid flows through the chamber, the concentration of particles within the chamber increases relative to the concentration in the particle-containing fluid supplied at the sample input. Where the particles are cells, the concentration or number of cells in zone 931 preferably becomes great enough to perform a polymerase chain reaction (PCR) analysis of polynucleotides released from the cells in a downstream processing module.
Enrichment zone 931 thus prepares an enriched particle sample from particles of particle-containing fluids received therein. The enriched particle sample has a substantially higher ratio of particles per volume of fluid (PPVF) than the corresponding ratio of the particle-containing fluid received by the enrichment zone. The PPVF of the enriched particle sample is preferably at least about 25 times, preferably about 250 times, more preferably about 1,000 times greater than the PPVF of the particle-containing fluid.
After a sufficient volume of particle containing fluid has been received by enrichment zone 931, valve 913 is closed thereby blocking further flow of fluid into the enrichment zone, and preventing material in zone 931 from returning to the sample introduction port 180. Valves 915, 919 are then opened, preferably upon actuating heat sources associated therewith. When opened, valve 919 allows actuator 168 to push enriched sample, and valve 915 allows the enriched sample to move downstream.
Actuator 168 provides a motive force that moves the enriched particle sample from enrichment zone 931. Actuator 168 is preferably a gas actuator, which provides a gas pressure upon actuation of a heat source 975, which is in thermal communication with a volume of gas 977. Actuation of heat source 975 raises the temperature and, therefore the pressure, of gas 977. The flow through member and the fluid therein substantially prevents gas from escaping the enrichment zone. Thus, the resulting gas pressure moves the enriched particle sample downstream from the enrichment zone 931.
The gas actuator may include elements to facilitate alternative pressure generation techniques such as chemical pressure generation. In another embodiment, the actuator may decrease a volume of gas associated with an upstream portion of the enrichment zone to thereby create a pressure differential across the sample that moves the sample from the enrichment zone. An example of such an element is a mechanical actuator, such as a plunger or diagram.
Rather than generating a positive pressure upstream from the enrichment zone, the gas actuator may decrease a pressure downstream from the zone relative to a pressure upstream. For example, the gas actuator may include a cooling element in thermal contact with a volume of gas associated with a downstream portion of the zone. Contraction of the gas upon actuating the cooling element creates a gas pressure difference between the upstream and downstream portions of the enrichment zone to move the enriched particle sample from the enrichment zone. Alternatively, a mechanical actuator may be used increase a volume of gas associated with a downstream portion of the enrichment zone to thereby decrease the pressure of the gas and move the enriched particle sample from the enrichment zone.
The enriched particle sample is preferably moved downstream with essentially no dilution thereof, i.e., the concentration of the enriched particles is not substantially decreased upon movement from the enrichment zone 931. Thus, removal of particles from the enrichment channel of the present invention does not require diluting or otherwise contacting the particles with a fluid different from the fluid of the particle-containing fluid introduced to the enrichment channel. In contrast, in systems that concentrate substances by surface adsorption, removal of the adsorbed substances requires an elution fluid, which contacts and thereby dilutes the substances.
Upon removal from the enrichment zone of the present invention, the enriched particle sample is preferably received by downstream channel 937. Downstream channel 937 leads to other processing modules, which perform further processing of the enriched particle sample. In the embodiment of
2. Microdroplet Preparation Module
a. Characteristics of a Microdroplet
A microdroplet 802 is a discrete sample having a predetermined volume between, for example, about 1.0 picoliter and about 0.5 microliters. Thus, microdroplets prepared by microdroplet preparation module provide a known amount of sample for further processing. The volume of the microdroplet prepared by the microdroplet preparation module is preferably essentially independent of the viscosity, electrical conductivity, and osmotic strength of the fluid of the microdroplet.
Microdroplet 802 is preferably defined by upstream and downstream boundaries each formed by a respective gas liquid interface 804, 806. The liquid of the interface is formed by a surface of a liquid forming the microdroplet. The gas of the interface is gas present in the channels microfluidic of microfluidic device 901.
b. Structure and Operation of the Microdroplet Preparation Module
Referring to
As explained above, actuator 168 of the enriched zone pushes the enriched sample into the microdroplet preparation zone 800. The enriched sample moves until reaching positioning element 979. In general, a positioning element inhibits the downstream progress of a microfluidic sample to thereby position the sample at a desired location. However, as explained more fully below, the positioning element does not permanently inhibit progress of the sample. Rather, it allows the microfluidic sample to continue downstream at a predetermined later time.
The leading edge of microfluidic sample 808 that reaches positioning element 979 is positioned downstream from an opening 820 of gas actuator 170. Accordingly, a first portion 821 of microfluidic sample 808 is disposed upstream from opening 820 and a second portion 822 of microfluidic sample 808 is disposed downstream from opening 820.
Referring to
Continued actuation of gas actuator 170 overcomes the inhibitory effect of positioning element 979, thereby driving microdroplet 802 to a location downstream of microdroplet preparation zone 800 while the second portion 822 of the microfluidics sample moves upstream from microdroplet 802 to cell lysis module 160.
3. Cell Lysis Module
Referring back to
As shown in
As explained above, actuator 170 of the microdroplet preparation module 158 drives a microdroplet into cell lysis module 160. As the microdroplet moves into module 160, vented positioning element 200 positions microdroplet 802 in a lysing position with respect to electrodes 954. More specifically, as the microdroplet arrives in lysing module 160 it passes the opening of positioning element 200, because second positioning element 206 inhibits the microdroplet from flowing into vent 202. When the rear end of the microdroplet passes the opening of barrier 200, the propulsion gas from actuator 170 dissipates through vent 202, thereby substantially equalizing gas pressure upstream of microdroplet 802 with a pressure downstream of microdroplet 802. Thus, the microdroplet stops movement at a lysing position just downstream from barrier 200. Preferably, in the lysing position, substantially all of microdroplet 802 is disposed between an upstream edge 212 and a downstream edge 214 of electrodes 954.
After microdroplet 802 is placed in the cell lysing position, a pulse circuit of DAQ 126 supplies a pulsed voltage signal across electrodes 954. In response, electrodes 954 generate a pulsed electric field in the vicinity of the electrodes. Because the microdroplet is position in this vicinity, cells within the microdroplet are subjected to the pulsed field. Preferably, substantially all of the cells, such as greater than about 75%, of the microdroplet are subjected to an electric field sufficient to release intracellular material therefrom. The lysing module thus prepares a lysed microdroplet comprising a predetermined amount of sample.
A preferred pulse circuit is shown in
Intracellular material present in lysed microdroplet is accessible to further process steps. For example, DNA and/or RNA released from cells is accessible for amplification by a polymerase chain reaction. As used herein, the term lysing does not require that the cells be completely ruptured. Rather, lysing refers to the release of intracellular material. For example, rather than rupturing the cells, the electric field may increase the porosity of cell membranes by an amount that allows release of intracellular material without permanent rupture of the membranes.
Other lysing mechanisms may also be employed to release intracellular material from cells. For example, material may be released by subjecting cells to other forces including for example osmotic shock or pressure. Chemicals, selected from the group of surfactants, solvents, and antibiotics may be contacted with the cells. Mechanical shear methods may also be used to release intracellular materials.
The lysed microdroplet may be moved downstream to mixing module 160 for further processing. To move lysed microdroplet downstream, valve 216, which is disposed upstream of lysing zone 950, is closed. Valve 204 is also closed to prevent gas from exiting lysing zone 950 via vent. Actuator 170 is then actuated, as described above, to provide a gas pressure sufficient to move lysed microdroplet downstream of lysing zone 950.
In an alternative embodiment, a lysing module 300, as shown in
Lysing zone 302 operates as follows. The microfluidic sample 306 enters lysing zone 302 and moves downstream until a downstream interface 316 of the microfluidic sample 306 encounters positioning element 312. The positioning element 312 preferably increases a surface tension of the downstream interface of the microfluidic sample 306, thereby inhibiting further downstream movement and positioning a portion of the microfluidic sample in a lysing position with respect to electrodes 308. The lysing position is defined as the location of the portion of the microfluidic sample disposed downstream of actuator 314 and upstream of positioning element 312. Preferably, actuator 314 and positioning element 312 are disposed adjacent electrodes 308 such that substantially all of the material present in the lysing position is subjected to the electric field upon actuating electrodes 308.
Actuation of electrodes 308 in the embodiment described above, provides an electrical field sufficient to release intracellular material from cells present in the portion of the microfluidic sample in the lysing position. Once a sufficient amount of intracellular material has been released, actuator 314 is actuated to prepare lysed microdroplet 304 from the microfluidic sample 306. Actuator 314 preferably provides a gas pressure sufficient to move the lysed microdroplet 304 to a downstream portion of a microfluidic device such as mixing module 166.
4. Mixing Module and Reagent Input Module
Referring back to
a. Reagent Input Module
Reagent input module 152 is essentially the same as microdroplet formation module 158, however, it is specifically designed for formation of a microdroplet of reagent having a predetermined volume which will yield a desired ratio of reagent to sample when mixed with the microdroplet from cell lysing module 160. Module 152 includes an input port 420, a valve 422, and an actuator 172, each of which joins a reagent source channel 428. An overflow channel 424, which also joins reagents source channel 428, may also be provided. Actuator 172 may include a second positioning element 432 to prevent liquid from entering therein.
Reagent materials, which preferably comprise at least one liquid, are introduced via input port 420, such as with a pipette or syringe. Examples of suitable reagent materials include substances to facilitate further processing of the lysed cell sample, such as enzymes and other materials for amplifying DNA therein by polymerase chain reaction (PCR). The reagent material moves downstream within reagent source channel 428 until a downstream portion of the reagent material contacts a positioning element 426. Any additional reagent material that continues to be received within reagent source module preferably enters overflow channel 424. When the introduction of reagent is complete, valve 422 is closed to prevent reagent from exiting reagent source channel via reagent source port 420.
b. Mixing Module
Mixing zone 958 of the mixing module includes adjoined first and second channels 410, 412. Materials moving downstream toward mixing zone 958 contact one another and preferably mix therein. Because of the micro-scale dimensions of mixing zone 958, the sample and reagent materials preferably mix by diffusion even in the absence of other sources of mass transport, such as mechanical agitation. It should be understood however, that agitation forces, such as acoustic waves may be applied to enhance mixing within mixing zone 958.
c. Operation of Mixing Module and Reagent Input Module
Reagent source module 152 and mixing module 166 preferably operate as follows. When a lysed sample from lysing zone 950 is ready to be mixed with reagent material, actuator 172 is actuated to prepare a microdroplet of reagent. The microdroplet of reagent is prepared from the portion of reagent material downstream of an opening 430 of actuator 172 and upstream of positioning element 427. Thus, assuming that the dimensions of the reagent source channel 428 are constant, the volume of the microdroplet of reagent is determined by the distance between the positioning element 426 and the actuator opening 430.
The microdroplet of reagent moves downstream toward channel 412 of reagent mixing zone. Meanwhile, a sample of lysed material, such as a lysed microdroplet, is moved downstream from lysing zone 950 toward channel 410 of mixing zone 958. Actuator 170 may provide the motive force to move the lysed microdroplet downstream. Alternatively, as discussed above, another actuator may be disposed upstream of lysing zone 950 but downstream of actuator 170 to provide the necessary motive force.
The sample and reagent material enter a downstream channel 438 of mixing zone 958, where the materials contact and mix. Because both the lysed sample and reagent material are mixed in the form of microdroplets, mixing zone 958 prepares an amount of mixed material having a predetermined ratio of sample to reagent. The volumes of microdroplets prepared within microfluidic device 110 are preferably independent of physical properties, such as viscosity, electrical conductivity, and osmotic strength, of the microdroplets. Thus, mixing zone 958 prepares an amount of mixed material having a sample to reagent material that is also independent of the physical and chemical properties of the mixed materials. A vent 440, which is downstream of the various zones of the microfluidic device 110 ensures that downstream pressure buildup does not inhibit downstream movement of samples within microfluidic device 110.
5. DNA Manipulation Module
The mixed lysed cell sample and reagent are received within a DNA manipulation zone 971 of DNA manipulation module 162. Module 162 can perform, for example, restriction, digestion, ligation, hybridization and amplification of DNA material. In one embodiment, DNA manipulation zone 971 is configured to perform PCR amplification of nucleic acids present within the lysed cell sample. Vent 440 prevents pressure from increasing within zone 971 as the lysed cell sample and reagent are being introduced thereto. Valves 972 and 973 of DNA manipulation module 162 may be closed to prevent substances therein zone from exiting, such as by evaporation, during PCR amplification. The DNA manipulation zone is configured with heat sources under control of computer 127 to allow thermal cycling of DNA manipulation zone during amplification, as understood by one of skill in the art.
System 901 includes also includes a detector 981 to detect the presence of amplified polynucleotides produced by PCR. Detector 981 is preferably an optical detector in optical communication, such as by a fiber optic 981, with zone 971. A light source, such as a laser diode, introduces light to DNA Manipulation zone 971 to generate fluorescence indicative of the amount of amplified polynucleotides present therein. The fluorescence arises from fluorescent tags, included in the reagent and associated with the polynucleotides upon amplification.
C. Preferred Positioning Elements
Preferred positioning elements are discussed below.
1. Non-Wetting Positioning Elements
A positioning element 979 may be formed by a non-wetting material disposed to contact a microfluidic sample. The physio-chemical properties of the non-wetting material are chosen upon considering the type of liquid forming the microfluidic sample. For example, where the microfluidic sample is an aqueous sample, the positioning element preferably comprises a hydrophobic material. An exemplary hydrophobic material includes a non-polar organic compound, such as an aliphatic silane, which can be formed by modifying an internal surface of microfluidic device 901. For microfluidic samples formed of organic solvents, the non-wetting material may comprise a hydrophilic material.
When microfluidic sample 808 encounters positioning element 979, the liquid of the microfluidic sample experiences an increased surface tension at downstream interface 810, which increased surface tension inhibits continued downstream motion of microfluidic sample 808. Increasing the gas pressure difference between upstream and downstream portions of the microfluidic sample overcomes the resistance and moves the microfluidic sample downstream.
2. Capillary Assisted Positioning Elements
Referring to
The volume of the microfluidic sample encountering the CAFB preferably has a larger volume than a volume of the loading zone 704 to ensure that the microfluidic sample will advance fully to opening. For fluids that have similar surface tensions and interface properties as water, the depth d.sub.1 of the loading zone 704 is preferably about 50% or less of the respective depths d.sub.2, d.sub.3 of the stop and feed zones.
The tendency of a microfluidic sample to move in a given direction is governed by the ratio between the mean radius of curvature (MRC) of the front of the microfluidic sample and the MRC of the back of the microfluidic sample. These curvatures depend upon the contact angle of the fluid of the sample and the dimensions of the zone in which the microdroplet is moving. A MRC r.sub.1 of a microdroplet interface in the loading zone is preferably smaller than a MRC r.sub.2 of a droplet interface within the feed zone or a MRC r.sub.3 of a droplet interface within the stop zone. The MRC r.sub.2 is preferably larger than the MRC r.sub.3. Thus, the radius of curvature of the downstream microdroplet interface increases upon encountering the stop zone thereby inhibiting further downstream movement. Preferably, the contact angle of the fluid with the wall is substantially constant throughout the capillary assisted loading zone.
3. Vented Positioning Elements
Referring to
An open state of a valve 512 allows passage of gas between zone 510 and vent 508. A closed state of valve 512 prevents such passage of gas. Valve 514 is preferably thermally actuated and includes a mass 514 of TRS.
An actuator 518 is disposed upstream of positioning element 500. Actuator 518 is preferably a gas actuator and may include a heat source 520 to heat a gas associated with actuator 518. Actuator 518 may include a positioning element 522, such as non-wetting material, to substantially prevent fluid from the microfluidic sample from entering therein.
Positioning element 500 preferably operates as follows. Referring to
Referring to
Referring to
4. Active Fluid Positioning Elements
Referring to
In operation, microfluidic preparation module 652 receives the microfluidic sample 666, which moves downstream because of a motive force provided by the second actuator 660. The motive force is preferably an upstream gas pressure, which is greater than a downstream gas pressure acting upon the microfluidic sample 666. The microfluidic sample moves downstream until a downstream portion 670 thereof encounters active positioning element 654, which preferably comprises a sensor 672 having electrical leads 674. The leads 674 are in electrical communication with I/O pins of the microfluidic device to allow signals from sensor 672 to be received by a DAQ.
Sensing element 672 is preferably a pair of electrical contacts. To sense the presence of the liquid, DAQ 126 applies a small voltage across leads 674 and measures the resultant current. As the liquid of the microfluidic sample contacts the first and second contacts, the current passing therebetween changes, thereby indicating to DAQ 126 that the liquid has arrived at sensor 672.
Upon recognition that the liquid has arrived at sensor 672, the DAQ instructs second actuator 660 to decrease a downstream motive force acting upon the microfluidic sample 666. For example, DAQ may reduce a current flowing through a heat source 676 associated with second actuator 660 thereby reducing a temperature of a gas therein. The temperature reduction reduces the gas pressure acting upon a upstream portion 678 of microfluidic sample thereby inhibiting the downstream motion of the microfluidic sample 666. The microfluidic sample is positioned such that a first portion 680 is located downstream of actuator 656 and a second portion 682 is located upstream of actuator 656.
To prepare microdroplet 668, DAQ 126 actuates actuator to provide a motive force which prepares the microdroplet 668 from the first portion 680 of microfluidic sample 666. Microdroplet 668 moves downstream while the second portion 682 of the microfluidic sample 666 moves upstream from actuator 656. During microdroplet preparation, valve 658 may be closed to substantially isolate the actuator 656 from second actuator 660 and other upstream portions of the microfluidic device.
The active positioning element preferably operates as a closed loop element that provides feedback from sensor 672 to the DAQ. The feedback is indicated when a microfluidic sample has reached a predetermined position within the microfluidic device. Upon receiving the feedback, the DAQ changes the state of the actuator providing the motive force to move the microdroplet.
While the above invention has been described with reference to certain preferred embodiments, it should be kept in mind that the scope of the present invention is not limited to these. Thus, one skilled in the art may find variations of these preferred embodiments which, nevertheless, fall within the spirit of the present invention, whose scope is defined by the claims set forth below.
This application is a continuation of application Ser. No. 11/929,971, filed Oct. 30, 2007, which is a continuation of application Ser. No. 10/075,371, filed Feb. 15, 2002, which is a continuation-in-part of application Ser. No. 10/014,519, filed Dec. 14, 2001, application Ser. No. 09/953,921, filed Sep. 18, 2001, and application Ser. No. 09/819,105, filed Mar. 28, 2001, and claiming priority of provisional application No. 60/307,638 filed Jul. 26, 2001. Each of the above-mentioned applications are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
1434314 | Raich | Oct 1922 | A |
1616419 | Wilson | Feb 1927 | A |
1733401 | Lovekin | Aug 1930 | A |
D189404 | Nicolle | Dec 1960 | S |
3528449 | Witte et al. | Sep 1970 | A |
3813316 | Chakrabarty et al. | May 1974 | A |
3985649 | Eddelman | Oct 1976 | A |
4018089 | Dzula et al. | Apr 1977 | A |
4018652 | Lanham et al. | Apr 1977 | A |
4038192 | Serur | Jul 1977 | A |
4055395 | Honkawa et al. | Oct 1977 | A |
D249706 | Adamski | Sep 1978 | S |
4139005 | Dickey | Feb 1979 | A |
D252157 | Kronish et al. | Jun 1979 | S |
D252341 | Thomas | Jul 1979 | S |
D254687 | Fadler et al. | Apr 1980 | S |
4212744 | Oota | Jul 1980 | A |
D261033 | Armbruster | Sep 1981 | S |
D261173 | Armbruster | Oct 1981 | S |
4301412 | Hill et al. | Nov 1981 | A |
4439526 | Columbus | Mar 1984 | A |
4457329 | Werley et al. | Jul 1984 | A |
4466740 | Kano et al. | Aug 1984 | A |
4504582 | Swann | Mar 1985 | A |
4522786 | Ebersole | Jun 1985 | A |
D279817 | Chen et al. | Jul 1985 | S |
D282208 | Lowry | Jan 1986 | S |
4599315 | Terasaki et al. | Jul 1986 | A |
4612873 | Eberle | Sep 1986 | A |
4612959 | Costello | Sep 1986 | A |
D288478 | Carlson et al. | Feb 1987 | S |
4647432 | Wakatake | Mar 1987 | A |
4654127 | Baker et al. | Mar 1987 | A |
4673657 | Christian | Jun 1987 | A |
4683195 | Mullis et al. | Jul 1987 | A |
4683202 | Mullis | Jul 1987 | A |
D292735 | Lovborg | Nov 1987 | S |
4720374 | Ramachandran | Jan 1988 | A |
4798693 | Mase et al. | Jan 1989 | A |
4800022 | Leonard | Jan 1989 | A |
4841786 | Schulz | Jun 1989 | A |
D302294 | Hillman | Jul 1989 | S |
4871779 | Killat et al. | Oct 1989 | A |
4895650 | Wang | Jan 1990 | A |
4919829 | Gates et al. | Apr 1990 | A |
4921809 | Shiff et al. | May 1990 | A |
4935342 | Seligson et al. | Jun 1990 | A |
4946562 | Guruswamy | Aug 1990 | A |
4949742 | Rando et al. | Aug 1990 | A |
D310413 | Bigler et al. | Sep 1990 | S |
4963498 | Hillman | Oct 1990 | A |
4967950 | Legg et al. | Nov 1990 | A |
D312692 | Bradley | Dec 1990 | S |
4978502 | Dole et al. | Dec 1990 | A |
4978622 | Mishell et al. | Dec 1990 | A |
4989626 | Takagi et al. | Feb 1991 | A |
5001417 | Pumphrey et al. | Mar 1991 | A |
5004583 | Guruswamy et al. | Apr 1991 | A |
5048554 | Kremer | Sep 1991 | A |
5053199 | Keiser et al. | Oct 1991 | A |
5060823 | Perlman | Oct 1991 | A |
5061336 | Soane | Oct 1991 | A |
5064618 | Baker et al. | Nov 1991 | A |
5071531 | Soane | Dec 1991 | A |
5091328 | Miller | Feb 1992 | A |
D324426 | Fan et al. | Mar 1992 | S |
5096669 | Lauks et al. | Mar 1992 | A |
D325638 | Sloat et al. | Apr 1992 | S |
5126002 | Iwata et al. | Jun 1992 | A |
5126022 | Soane et al. | Jun 1992 | A |
D328135 | Fan et al. | Jul 1992 | S |
D328794 | Frenkel et al. | Aug 1992 | S |
5135627 | Soane | Aug 1992 | A |
5135872 | Pouletty et al. | Aug 1992 | A |
5147606 | Charlton et al. | Sep 1992 | A |
5169512 | Wiedenmann et al. | Dec 1992 | A |
D333522 | Gianino | Feb 1993 | S |
5186339 | Heissler | Feb 1993 | A |
5192507 | Taylor et al. | Mar 1993 | A |
5208163 | Charlton et al. | May 1993 | A |
5223226 | Whittmer et al. | Jun 1993 | A |
D338275 | Fischer et al. | Aug 1993 | S |
5250263 | Manz | Oct 1993 | A |
5252743 | Barrett et al. | Oct 1993 | A |
5256376 | Callan et al. | Oct 1993 | A |
5275787 | Yuguchi et al. | Jan 1994 | A |
5282950 | Dietze et al. | Feb 1994 | A |
5296375 | Kricka et al. | Mar 1994 | A |
5304477 | Nagoh et al. | Apr 1994 | A |
5304487 | Wilding et al. | Apr 1994 | A |
D347478 | Pinkney | May 1994 | S |
5311896 | Kaartinen et al. | May 1994 | A |
5311996 | Duffy et al. | May 1994 | A |
5316727 | Suzuki et al. | May 1994 | A |
5327038 | Culp | Jul 1994 | A |
5339486 | Persic | Aug 1994 | A |
D351475 | Gerber | Oct 1994 | S |
D351913 | Hieb et al. | Oct 1994 | S |
5364591 | Green et al. | Nov 1994 | A |
5372946 | Cusak et al. | Dec 1994 | A |
5374395 | Robinson | Dec 1994 | A |
5389339 | Petschek et al. | Feb 1995 | A |
D356232 | Armstrong et al. | Mar 1995 | S |
5397709 | Berndt | Mar 1995 | A |
5401465 | Smethers et al. | Mar 1995 | A |
5411708 | Moscetta et al. | May 1995 | A |
5414245 | Hackleman | May 1995 | A |
5416000 | Allen et al. | May 1995 | A |
5422271 | Chen et al. | Jun 1995 | A |
5422284 | Lau | Jun 1995 | A |
5427946 | Kricka et al. | Jun 1995 | A |
5474796 | Brennan | Dec 1995 | A |
D366116 | Biskupski | Jan 1996 | S |
5486335 | Wilding et al. | Jan 1996 | A |
5494639 | Grzegorzewski | Feb 1996 | A |
5498392 | Wilding et al. | Mar 1996 | A |
5503803 | Brown | Apr 1996 | A |
5516410 | Schneider et al. | May 1996 | A |
5519635 | Miyake et al. | May 1996 | A |
5529677 | Schneider et al. | Jun 1996 | A |
5559432 | Logue | Sep 1996 | A |
5565171 | Dovichi et al. | Oct 1996 | A |
5569364 | Hooper et al. | Oct 1996 | A |
5578270 | Reichler et al. | Nov 1996 | A |
5578818 | Kain et al. | Nov 1996 | A |
5579928 | Anukwuem | Dec 1996 | A |
5580523 | Bard | Dec 1996 | A |
5582884 | Ball et al. | Dec 1996 | A |
5585069 | Zanucchi et al. | Dec 1996 | A |
5585089 | Queen et al. | Dec 1996 | A |
5585242 | Bouma et al. | Dec 1996 | A |
5587128 | Wilding et al. | Dec 1996 | A |
5589136 | Northrup et al. | Dec 1996 | A |
5593838 | Zanzucchi et al. | Jan 1997 | A |
5595708 | Berndt | Jan 1997 | A |
5599432 | Manz et al. | Feb 1997 | A |
5599503 | Manz et al. | Feb 1997 | A |
5599667 | Arnold, Jr. et al. | Feb 1997 | A |
5601727 | Bormann et al. | Feb 1997 | A |
5603351 | Cherukuri et al. | Feb 1997 | A |
5605662 | Heller et al. | Feb 1997 | A |
D378782 | LaBarbera et al. | Apr 1997 | S |
5628890 | Carter et al. | May 1997 | A |
5630920 | Friese et al. | May 1997 | A |
5631337 | Sassi et al. | May 1997 | A |
5632876 | Zanzucchi et al. | May 1997 | A |
5632957 | Heller et al. | May 1997 | A |
5635358 | Wilding et al. | Jun 1997 | A |
5637469 | Wilding et al. | Jun 1997 | A |
5639423 | Northrup et al. | Jun 1997 | A |
5643738 | Zanzucchi et al. | Jul 1997 | A |
5646039 | Northrup et al. | Jul 1997 | A |
5647994 | Tuunanen et al. | Jul 1997 | A |
5651839 | Rauf | Jul 1997 | A |
5652149 | Mileaf et al. | Jul 1997 | A |
D382346 | Buhler et al. | Aug 1997 | S |
D382647 | Staples et al. | Aug 1997 | S |
5667976 | Van Ness et al. | Sep 1997 | A |
5671303 | Shieh et al. | Sep 1997 | A |
5674394 | Whitmore | Oct 1997 | A |
5674742 | Northrup et al. | Oct 1997 | A |
5681484 | Zanzucchi et al. | Oct 1997 | A |
5681529 | Taguchi et al. | Oct 1997 | A |
5683657 | Mian | Nov 1997 | A |
5699157 | Parce | Dec 1997 | A |
5700637 | Southern | Dec 1997 | A |
5705813 | Apffel et al. | Jan 1998 | A |
5726026 | Wilding et al. | Mar 1998 | A |
5726404 | Brody | Mar 1998 | A |
5726944 | Pelley et al. | Mar 1998 | A |
5731212 | Gavin et al. | Mar 1998 | A |
5744366 | Kricka et al. | Apr 1998 | A |
5747666 | Willis | May 1998 | A |
5750015 | Soane et al. | May 1998 | A |
5755942 | Zanzucchi et al. | May 1998 | A |
5763262 | Wong et al. | Jun 1998 | A |
5770029 | Nelson et al. | Jun 1998 | A |
5770388 | Vorpahl | Jun 1998 | A |
5772966 | Maracas et al. | Jun 1998 | A |
5779868 | Parce et al. | Jul 1998 | A |
5787032 | Heller et al. | Jul 1998 | A |
5788814 | Sun et al. | Aug 1998 | A |
5800600 | Lima-Marques et al. | Sep 1998 | A |
5800690 | Chow et al. | Sep 1998 | A |
5804436 | Okun et al. | Sep 1998 | A |
D399959 | Prokop et al. | Oct 1998 | S |
5827481 | Bente et al. | Oct 1998 | A |
5842106 | Thaler et al. | Nov 1998 | A |
5842787 | Kopf-Sill et al. | Dec 1998 | A |
5846396 | Zanzucchi et al. | Dec 1998 | A |
5846493 | Bankier et al. | Dec 1998 | A |
5849208 | Hayes et al. | Dec 1998 | A |
5849486 | Heller et al. | Dec 1998 | A |
5849489 | Heller | Dec 1998 | A |
5849598 | Wilson et al. | Dec 1998 | A |
5852495 | Parce | Dec 1998 | A |
5856174 | Lipshutz et al. | Jan 1999 | A |
5858187 | Ramsey et al. | Jan 1999 | A |
5858188 | Soane et al. | Jan 1999 | A |
5863502 | Southgate et al. | Jan 1999 | A |
5863708 | Zanzucchi et al. | Jan 1999 | A |
5863801 | Southgate et al. | Jan 1999 | A |
5866345 | Wilding et al. | Feb 1999 | A |
5869004 | Parce et al. | Feb 1999 | A |
5869244 | Martin et al. | Feb 1999 | A |
5872010 | Karger et al. | Feb 1999 | A |
5872623 | Stabile et al. | Feb 1999 | A |
5874046 | Megerle | Feb 1999 | A |
5876675 | Kennedy | Mar 1999 | A |
5880071 | Parce et al. | Mar 1999 | A |
5882465 | McReynolds | Mar 1999 | A |
5883211 | Sassi et al. | Mar 1999 | A |
5885432 | Hooper et al. | Mar 1999 | A |
5885470 | Parce et al. | Mar 1999 | A |
5895762 | Greenfield et al. | Apr 1999 | A |
5900130 | Benvegnu et al. | May 1999 | A |
5912124 | Kumar | Jun 1999 | A |
5912134 | Shartle | Jun 1999 | A |
5916522 | Boyd et al. | Jun 1999 | A |
5916776 | Kumar | Jun 1999 | A |
5919646 | Okun et al. | Jul 1999 | A |
5919711 | Boyd et al. | Jul 1999 | A |
5922591 | Anderson et al. | Jul 1999 | A |
5927547 | Papen et al. | Jul 1999 | A |
5928880 | Wilding et al. | Jul 1999 | A |
5929208 | Heller et al. | Jul 1999 | A |
D413391 | Lapeus et al. | Aug 1999 | S |
5932799 | Moles | Aug 1999 | A |
5935401 | Amigo | Aug 1999 | A |
5939291 | Loewy et al. | Aug 1999 | A |
5942443 | Parce et al. | Aug 1999 | A |
D413677 | Dumitrescu et al. | Sep 1999 | S |
5948227 | Dubrow | Sep 1999 | A |
5955028 | Chow | Sep 1999 | A |
5955029 | Wilding et al. | Sep 1999 | A |
5957579 | Kopf-Sill et al. | Sep 1999 | A |
5958203 | Parce et al. | Sep 1999 | A |
5958694 | Nikiforov | Sep 1999 | A |
5959221 | Boyd et al. | Sep 1999 | A |
5959291 | Jensen | Sep 1999 | A |
5964995 | Nikiforov et al. | Oct 1999 | A |
5964997 | McBride | Oct 1999 | A |
5965001 | Chow et al. | Oct 1999 | A |
5965410 | Chow et al. | Oct 1999 | A |
5965886 | Sauer et al. | Oct 1999 | A |
5968745 | Thorp et al. | Oct 1999 | A |
5972187 | Parce et al. | Oct 1999 | A |
5973138 | Collis | Oct 1999 | A |
D417009 | Boyd | Nov 1999 | S |
5976336 | Dubrow et al. | Nov 1999 | A |
5980704 | Cherukuri et al. | Nov 1999 | A |
5980719 | Cherukuri et al. | Nov 1999 | A |
5981735 | Thatcher et al. | Nov 1999 | A |
5989402 | Chow et al. | Nov 1999 | A |
5992820 | Fare et al. | Nov 1999 | A |
5993611 | Moroney, III et al. | Nov 1999 | A |
5993750 | Ghosh et al. | Nov 1999 | A |
5997708 | Craig | Dec 1999 | A |
6001229 | Ramsey | Dec 1999 | A |
6001231 | Kopf-Sill | Dec 1999 | A |
6001307 | Naka et al. | Dec 1999 | A |
6004515 | Parce et al. | Dec 1999 | A |
6007690 | Nelson et al. | Dec 1999 | A |
6010607 | Ramsey | Jan 2000 | A |
6010608 | Ramsey | Jan 2000 | A |
6010627 | Hood, III | Jan 2000 | A |
6012902 | Parce | Jan 2000 | A |
D420747 | Dumitrescu et al. | Feb 2000 | S |
D421130 | Cohen et al. | Feb 2000 | S |
6024920 | Cunanan | Feb 2000 | A |
D421653 | Purcell | Mar 2000 | S |
6033546 | Ramsey | Mar 2000 | A |
6043080 | Lipshutz et al. | Mar 2000 | A |
6046056 | Parce et al. | Apr 2000 | A |
6048734 | Burns et al. | Apr 2000 | A |
6054034 | Soane et al. | Apr 2000 | A |
6054277 | Furcht et al. | Apr 2000 | A |
6056860 | Amigo et al. | May 2000 | A |
6057149 | Burns et al. | May 2000 | A |
6062261 | Jacobson et al. | May 2000 | A |
6063341 | Fassbind et al. | May 2000 | A |
6063589 | Kellogg et al. | May 2000 | A |
6068752 | Dubrow et al. | May 2000 | A |
6071478 | Chow | Jun 2000 | A |
6074725 | Kennedy | Jun 2000 | A |
6074827 | Nelson et al. | Jun 2000 | A |
D428497 | Lapeus et al. | Jul 2000 | S |
6086740 | Kennedy | Jul 2000 | A |
6096509 | Okun et al. | Aug 2000 | A |
6100541 | Nagle et al. | Aug 2000 | A |
6102897 | Lang | Aug 2000 | A |
6103537 | Ullman et al. | Aug 2000 | A |
6106685 | McBride et al. | Aug 2000 | A |
6110343 | Ramsey et al. | Aug 2000 | A |
6123205 | Dumitrescu et al. | Sep 2000 | A |
6123798 | Gandhi et al. | Sep 2000 | A |
6130098 | Handique et al. | Oct 2000 | A |
6132580 | Mathies et al. | Oct 2000 | A |
6132684 | Marino | Oct 2000 | A |
6133436 | Koster et al. | Oct 2000 | A |
D433759 | Mathis et al. | Nov 2000 | S |
6143250 | Tajima | Nov 2000 | A |
6149787 | Chow et al. | Nov 2000 | A |
6156199 | Zuk, Jr. | Dec 2000 | A |
6158269 | Dorenkott et al. | Dec 2000 | A |
6167910 | Chow | Jan 2001 | B1 |
6168948 | Anderson et al. | Jan 2001 | B1 |
6171850 | Nagle et al. | Jan 2001 | B1 |
6174675 | Chow et al. | Jan 2001 | B1 |
6180950 | Olsen | Jan 2001 | B1 |
D438311 | Yamanishi et al. | Feb 2001 | S |
6190619 | Kilcoin et al. | Feb 2001 | B1 |
D438632 | Miller | Mar 2001 | S |
D438633 | Miller | Mar 2001 | S |
D439673 | Brophy et al. | Mar 2001 | S |
6197595 | Anderson et al. | Mar 2001 | B1 |
6211989 | Wulf et al. | Apr 2001 | B1 |
6213151 | Jacobson et al. | Apr 2001 | B1 |
6221600 | MacLeod et al. | Apr 2001 | B1 |
6228635 | Armstrong et al. | May 2001 | B1 |
6232072 | Fisher | May 2001 | B1 |
6235175 | Dubrow et al. | May 2001 | B1 |
6235313 | Mathiowitz et al. | May 2001 | B1 |
6235471 | Knapp et al. | May 2001 | B1 |
6236456 | Giebeler et al. | May 2001 | B1 |
6236581 | Foss et al. | May 2001 | B1 |
6238626 | Higuchi et al. | May 2001 | B1 |
6251343 | Dubrow et al. | Jun 2001 | B1 |
6254826 | Acosta et al. | Jul 2001 | B1 |
6259635 | Khouri et al. | Jul 2001 | B1 |
6261431 | Mathies et al. | Jul 2001 | B1 |
6267858 | Parce et al. | Jul 2001 | B1 |
D446306 | Ochi et al. | Aug 2001 | S |
6271021 | Burns et al. | Aug 2001 | B1 |
6274089 | Chow et al. | Aug 2001 | B1 |
6280967 | Ransom et al. | Aug 2001 | B1 |
6281008 | Komai et al. | Aug 2001 | B1 |
6284113 | Bjornson et al. | Sep 2001 | B1 |
6287254 | Dodds | Sep 2001 | B1 |
6287774 | Nikiforov | Sep 2001 | B1 |
6291248 | Haj-Ahmad | Sep 2001 | B1 |
6294063 | Becker et al. | Sep 2001 | B1 |
6302134 | Kellogg et al. | Oct 2001 | B1 |
6302304 | Spencer | Oct 2001 | B1 |
6303343 | Kopf-Sill | Oct 2001 | B1 |
6306273 | Wainright et al. | Oct 2001 | B1 |
6306590 | Mehta et al. | Oct 2001 | B1 |
6319469 | Mian et al. | Nov 2001 | B1 |
6322683 | Wolk et al. | Nov 2001 | B1 |
6326083 | Yang et al. | Dec 2001 | B1 |
6326147 | Oldham et al. | Dec 2001 | B1 |
6326211 | Anderson et al. | Dec 2001 | B1 |
6334980 | Hayes et al. | Jan 2002 | B1 |
6337435 | Chu et al. | Jan 2002 | B1 |
6353475 | Jensen et al. | Mar 2002 | B1 |
6358387 | Kopf-Sill et al. | Mar 2002 | B1 |
6366924 | Parce | Apr 2002 | B1 |
6368871 | Christel et al. | Apr 2002 | B1 |
6370206 | Schenk | Apr 2002 | B1 |
6375185 | Lin | Apr 2002 | B1 |
6375901 | Robotti et al. | Apr 2002 | B1 |
6379884 | Wada et al. | Apr 2002 | B2 |
6379929 | Burns et al. | Apr 2002 | B1 |
6379974 | Parce et al. | Apr 2002 | B1 |
6382254 | Yang et al. | May 2002 | B1 |
6391541 | Petersen et al. | May 2002 | B1 |
6391623 | Besemer et al. | May 2002 | B1 |
6395161 | Schneider et al. | May 2002 | B1 |
6398956 | Coville et al. | Jun 2002 | B1 |
6399025 | Chow | Jun 2002 | B1 |
6399389 | Parce et al. | Jun 2002 | B1 |
6399952 | Maier et al. | Jun 2002 | B1 |
6401552 | Elkins | Jun 2002 | B1 |
6403338 | Knapp et al. | Jun 2002 | B1 |
6408878 | Unger et al. | Jun 2002 | B2 |
6413401 | Chow et al. | Jul 2002 | B1 |
6416642 | Alajoki et al. | Jul 2002 | B1 |
6420143 | Kopf-Sill | Jul 2002 | B1 |
6425972 | McReynolds | Jul 2002 | B1 |
D461906 | Pham | Aug 2002 | S |
6428987 | Franzen | Aug 2002 | B2 |
6430512 | Gallagher | Aug 2002 | B1 |
6432366 | Ruediger et al. | Aug 2002 | B2 |
6440725 | Pourahmadi et al. | Aug 2002 | B1 |
D463031 | Slomski et al. | Sep 2002 | S |
6444461 | Knapp et al. | Sep 2002 | B1 |
6447661 | Chow et al. | Sep 2002 | B1 |
6447727 | Parce et al. | Sep 2002 | B1 |
6448064 | Vo-Dinh et al. | Sep 2002 | B1 |
6453928 | Kaplan et al. | Sep 2002 | B1 |
6465257 | Parce et al. | Oct 2002 | B1 |
6468761 | Yang et al. | Oct 2002 | B2 |
6472141 | Nikiforov | Oct 2002 | B2 |
6475364 | Dubrow et al. | Nov 2002 | B1 |
D467348 | McMichael et al. | Dec 2002 | S |
D467349 | Niedbala et al. | Dec 2002 | S |
6488897 | Dubrow et al. | Dec 2002 | B2 |
6495104 | Unno et al. | Dec 2002 | B1 |
6498497 | Chow et al. | Dec 2002 | B1 |
6500323 | Chow et al. | Dec 2002 | B1 |
6500390 | Boulton et al. | Dec 2002 | B1 |
D468437 | McMenamy et al. | Jan 2003 | S |
6506609 | Wada et al. | Jan 2003 | B1 |
6509193 | Tajima | Jan 2003 | B1 |
6511853 | Kopf-Sill et al. | Jan 2003 | B1 |
D470595 | Crisanti et al. | Feb 2003 | S |
6515753 | Maher | Feb 2003 | B2 |
6517783 | Horner et al. | Feb 2003 | B2 |
6520197 | Deshmukh et al. | Feb 2003 | B2 |
6521188 | Webster | Feb 2003 | B1 |
6524456 | Ramsey et al. | Feb 2003 | B1 |
6524790 | Kopf-Sill et al. | Feb 2003 | B1 |
D472324 | Rumore et al. | Mar 2003 | S |
6534295 | Tai et al. | Mar 2003 | B2 |
6537771 | Farinas et al. | Mar 2003 | B1 |
6540896 | Manz et al. | Apr 2003 | B1 |
6544734 | Briscoe et al. | Apr 2003 | B1 |
6547942 | Parce et al. | Apr 2003 | B1 |
6555389 | Ullman et al. | Apr 2003 | B1 |
6556923 | Gallagher et al. | Apr 2003 | B2 |
D474279 | Mayer et al. | May 2003 | S |
D474280 | Niedbala et al. | May 2003 | S |
6558916 | Veerapandian et al. | May 2003 | B2 |
6558945 | Kao | May 2003 | B1 |
6569607 | McReynolds | May 2003 | B2 |
6572830 | Burdon et al. | Jun 2003 | B1 |
6575188 | Parunak | Jun 2003 | B2 |
6576459 | Miles et al. | Jun 2003 | B2 |
6579453 | Bächler et al. | Jun 2003 | B1 |
6589729 | Chan et al. | Jul 2003 | B2 |
6592821 | Wada et al. | Jul 2003 | B1 |
6597450 | Andrews et al. | Jul 2003 | B1 |
6602474 | Tajima | Aug 2003 | B1 |
6613211 | McCormick et al. | Sep 2003 | B1 |
6613512 | Kopf-Sill et al. | Sep 2003 | B1 |
6613580 | Chow et al. | Sep 2003 | B1 |
6613581 | Wada et al. | Sep 2003 | B1 |
6614030 | Maher et al. | Sep 2003 | B2 |
6620625 | Wolk et al. | Sep 2003 | B2 |
6623860 | Hu et al. | Sep 2003 | B2 |
6627406 | Singh et al. | Sep 2003 | B1 |
D480814 | Lafferty et al. | Oct 2003 | S |
6632655 | Mehta et al. | Oct 2003 | B1 |
6633785 | Kasahara et al. | Oct 2003 | B1 |
D482796 | Oyama et al. | Nov 2003 | S |
6649358 | Parce et al. | Nov 2003 | B1 |
6664104 | Pourahmadi et al. | Dec 2003 | B2 |
6669831 | Chow et al. | Dec 2003 | B2 |
6670153 | Stern | Dec 2003 | B2 |
D484989 | Gebrian | Jan 2004 | S |
6681616 | Spaid et al. | Jan 2004 | B2 |
6681788 | Parce et al. | Jan 2004 | B2 |
6685813 | Williams et al. | Feb 2004 | B2 |
6692700 | Handique | Feb 2004 | B2 |
6695009 | Chien et al. | Feb 2004 | B2 |
6706519 | Kellogg et al. | Mar 2004 | B1 |
6720148 | Nikiforov | Apr 2004 | B1 |
6730206 | Ricco et al. | May 2004 | B2 |
6733645 | Chow | May 2004 | B1 |
6734401 | Bedingham et al. | May 2004 | B2 |
6737026 | Bergh et al. | May 2004 | B1 |
6740518 | Duong et al. | May 2004 | B1 |
D491272 | Alden et al. | Jun 2004 | S |
D491273 | Biegler et al. | Jun 2004 | S |
D491276 | Langille | Jun 2004 | S |
6750661 | Brooks et al. | Jun 2004 | B2 |
6752966 | Chazan | Jun 2004 | B1 |
6756019 | Dubrow et al. | Jun 2004 | B1 |
6766817 | da Silva | Jul 2004 | B2 |
6773567 | Wolk | Aug 2004 | B1 |
6777184 | Nikiforov et al. | Aug 2004 | B2 |
6783962 | Olander et al. | Aug 2004 | B1 |
D495805 | Lea et al. | Sep 2004 | S |
6787015 | Lackritz et al. | Sep 2004 | B2 |
6787016 | Tan et al. | Sep 2004 | B2 |
6790328 | Jacobson et al. | Sep 2004 | B2 |
6790330 | Gascoyne et al. | Sep 2004 | B2 |
6811668 | Berndt et al. | Nov 2004 | B1 |
6818113 | Williams et al. | Nov 2004 | B2 |
6819027 | Saraf | Nov 2004 | B2 |
6824663 | Boone | Nov 2004 | B1 |
D499813 | Wu | Dec 2004 | S |
D500142 | Crisanti et al. | Dec 2004 | S |
6827831 | Chow et al. | Dec 2004 | B1 |
6827906 | Bjornson et al. | Dec 2004 | B1 |
6838156 | Neyer et al. | Jan 2005 | B1 |
6838680 | Maher et al. | Jan 2005 | B2 |
6852287 | Ganesan | Feb 2005 | B2 |
6858185 | Kopf-Sill et al. | Feb 2005 | B1 |
6859698 | Schmeisser | Feb 2005 | B2 |
6861035 | Pham et al. | Mar 2005 | B2 |
6878540 | Pourahmadi et al. | Apr 2005 | B2 |
6878755 | Singh et al. | Apr 2005 | B2 |
6884628 | Hubbell et al. | Apr 2005 | B2 |
6887693 | McMillan et al. | May 2005 | B2 |
6893879 | Petersen et al. | May 2005 | B2 |
6900889 | Bjornson et al. | May 2005 | B2 |
6905583 | Wainright et al. | Jun 2005 | B2 |
6905612 | Dorian et al. | Jun 2005 | B2 |
6906797 | Kao et al. | Jun 2005 | B1 |
6908594 | Schaevitz et al. | Jun 2005 | B1 |
6911183 | Handique et al. | Jun 2005 | B1 |
6914137 | Baker | Jul 2005 | B2 |
6915679 | Chien et al. | Jul 2005 | B2 |
6918404 | Dias da Silva | Jul 2005 | B2 |
D508999 | Fanning et al. | Aug 2005 | S |
6939451 | Zhao et al. | Sep 2005 | B2 |
6942771 | Kayyem | Sep 2005 | B1 |
6958392 | Fomovskaia et al. | Oct 2005 | B2 |
D512155 | Matsumoto | Nov 2005 | S |
6964747 | Banerjee et al. | Nov 2005 | B2 |
6977163 | Mehta | Dec 2005 | B1 |
6984516 | Briscoe et al. | Jan 2006 | B2 |
D515707 | Sinohara et al. | Feb 2006 | S |
D516221 | Wohlstadter et al. | Feb 2006 | S |
7001853 | Brown et al. | Feb 2006 | B1 |
7004184 | Handique et al. | Feb 2006 | B2 |
D517554 | Yanagisawa et al. | Mar 2006 | S |
7010391 | Handique et al. | Mar 2006 | B2 |
7023007 | Gallagher | Apr 2006 | B2 |
7024281 | Unno | Apr 2006 | B1 |
7036667 | Greenstein et al. | May 2006 | B2 |
7037416 | Parce et al. | May 2006 | B2 |
7038472 | Chien | May 2006 | B1 |
7039527 | Tripathi et al. | May 2006 | B2 |
7040144 | Spaid et al. | May 2006 | B2 |
7049558 | Baer et al. | May 2006 | B2 |
D523153 | Akashi et al. | Jun 2006 | S |
7055695 | Greenstein et al. | Jun 2006 | B2 |
7060171 | Nikiforov et al. | Jun 2006 | B1 |
7066586 | da Silva | Jun 2006 | B2 |
7069952 | McReynolds et al. | Jul 2006 | B1 |
7099778 | Chien | Aug 2006 | B2 |
D528215 | Malmsater | Sep 2006 | S |
7101467 | Spaid | Sep 2006 | B2 |
7105304 | Nikiforov et al. | Sep 2006 | B1 |
D531321 | Godfrey et al. | Oct 2006 | S |
7118910 | Unger et al. | Oct 2006 | B2 |
7138032 | Gandhi et al. | Nov 2006 | B2 |
D534280 | Gomm et al. | Dec 2006 | S |
7148043 | Kordunsky et al. | Dec 2006 | B2 |
7150814 | Parce et al. | Dec 2006 | B1 |
7150999 | Shuck | Dec 2006 | B1 |
D535403 | Isozaki et al. | Jan 2007 | S |
7160423 | Chien et al. | Jan 2007 | B2 |
7161356 | Chien | Jan 2007 | B1 |
7169277 | Ausserer et al. | Jan 2007 | B2 |
7169618 | Skould | Jan 2007 | B2 |
D537951 | Okamoto et al. | Mar 2007 | S |
D538436 | Patadia et al. | Mar 2007 | S |
7192557 | Wu et al. | Mar 2007 | B2 |
7195986 | Bousse et al. | Mar 2007 | B1 |
7208125 | Dong | Apr 2007 | B1 |
7235406 | Woudenberg et al. | Jun 2007 | B1 |
7247274 | Chow | Jul 2007 | B1 |
D548841 | Brownell et al. | Aug 2007 | S |
D549827 | Maeno et al. | Aug 2007 | S |
7252928 | Hafeman et al. | Aug 2007 | B1 |
7270786 | Parunak et al. | Sep 2007 | B2 |
D554069 | Bolotin et al. | Oct 2007 | S |
D554070 | Bolotin et al. | Oct 2007 | S |
7276330 | Chow et al. | Oct 2007 | B2 |
D556914 | Okamoto et al. | Dec 2007 | S |
7303727 | Dubrow et al. | Dec 2007 | B1 |
D559995 | Handique et al. | Jan 2008 | S |
7323140 | Handique et al. | Jan 2008 | B2 |
7332130 | Handique | Feb 2008 | B2 |
7338760 | Gong et al. | Mar 2008 | B2 |
D566291 | Parunak et al. | Apr 2008 | S |
7351377 | Chazan et al. | Apr 2008 | B2 |
D569526 | Duffy et al. | May 2008 | S |
7374949 | Kuriger | May 2008 | B2 |
7390460 | Osawa et al. | Jun 2008 | B2 |
7419784 | Dubrow et al. | Sep 2008 | B2 |
7422669 | Jacobson et al. | Sep 2008 | B2 |
7440684 | Spaid et al. | Oct 2008 | B2 |
7476313 | Siddiqi | Jan 2009 | B2 |
7494577 | Williams et al. | Feb 2009 | B2 |
7494770 | Wilding et al. | Feb 2009 | B2 |
7514046 | Kechagia et al. | Apr 2009 | B2 |
7518726 | Rulison et al. | Apr 2009 | B2 |
7521186 | Burd Mehta | Apr 2009 | B2 |
7527769 | Bunch et al. | May 2009 | B2 |
D595423 | Johansson et al. | Jun 2009 | S |
7553671 | Sinclair et al. | Jun 2009 | B2 |
D596312 | Giraud et al. | Jul 2009 | S |
D598566 | Allaer | Aug 2009 | S |
D599234 | Ito | Sep 2009 | S |
7595197 | Brasseur | Sep 2009 | B2 |
7604938 | Takahashi et al. | Oct 2009 | B2 |
7635588 | King et al. | Dec 2009 | B2 |
7645581 | Knapp et al. | Jan 2010 | B2 |
7670559 | Chien et al. | Mar 2010 | B2 |
7674431 | Ganesan | Mar 2010 | B2 |
7704735 | Facer et al. | Apr 2010 | B2 |
7723123 | Murphy et al. | May 2010 | B1 |
D618820 | Wilson et al. | Jun 2010 | S |
7727371 | Kennedy et al. | Jun 2010 | B2 |
7727477 | Boronkay et al. | Jun 2010 | B2 |
7744817 | Bui | Jun 2010 | B2 |
D621060 | Handique | Aug 2010 | S |
7867776 | Kennedy et al. | Jan 2011 | B2 |
7892819 | Wilding et al. | Feb 2011 | B2 |
D637737 | Wilson et al. | May 2011 | S |
7998708 | Handique et al. | Aug 2011 | B2 |
8088616 | Handique | Jan 2012 | B2 |
8105783 | Handique | Jan 2012 | B2 |
8133671 | Williams et al. | Mar 2012 | B2 |
8182763 | Duffy et al. | May 2012 | B2 |
8273308 | Handique et al. | Sep 2012 | B2 |
D669597 | Cavada et al. | Oct 2012 | S |
8287820 | Williams et al. | Oct 2012 | B2 |
8323584 | Ganesan | Dec 2012 | B2 |
8323900 | Handique et al. | Dec 2012 | B2 |
8324372 | Brahmasandra et al. | Dec 2012 | B2 |
8415103 | Handique | Apr 2013 | B2 |
8420015 | Ganesan et al. | Apr 2013 | B2 |
8440149 | Handique | May 2013 | B2 |
8470586 | Wu et al. | Jun 2013 | B2 |
8473104 | Handique et al. | Jun 2013 | B2 |
20010012492 | Acosta et al. | Aug 2001 | A1 |
20010021355 | Baugh et al. | Sep 2001 | A1 |
20010023848 | Gjerde et al. | Sep 2001 | A1 |
20010038450 | McCaffrey et al. | Nov 2001 | A1 |
20010046702 | Schembri | Nov 2001 | A1 |
20010055765 | O'Keefe et al. | Dec 2001 | A1 |
20020001848 | Bedingham et al. | Jan 2002 | A1 |
20020008053 | Hansen et al. | Jan 2002 | A1 |
20020009015 | Laugharn et al. | Jan 2002 | A1 |
20020015667 | Chow | Feb 2002 | A1 |
20020021983 | Comte et al. | Feb 2002 | A1 |
20020037499 | Quake et al. | Mar 2002 | A1 |
20020039783 | McMillan et al. | Apr 2002 | A1 |
20020053399 | Soane et al. | May 2002 | A1 |
20020054835 | Robotti et al. | May 2002 | A1 |
20020055167 | Pourahmadi et al. | May 2002 | A1 |
20020058332 | Quake et al. | May 2002 | A1 |
20020060156 | Mathies et al. | May 2002 | A1 |
20020068357 | Mathies et al. | Jun 2002 | A1 |
20020141903 | Parunak et al. | Oct 2002 | A1 |
20020142471 | Handique et al. | Oct 2002 | A1 |
20020143297 | Francavilla et al. | Oct 2002 | A1 |
20020143437 | Handique et al. | Oct 2002 | A1 |
20020155477 | Ito | Oct 2002 | A1 |
20020169518 | Luoma et al. | Nov 2002 | A1 |
20020187557 | Hobbs et al. | Dec 2002 | A1 |
20030019522 | Parunak | Jan 2003 | A1 |
20030049174 | Ganesan | Mar 2003 | A1 |
20030049833 | Chen et al. | Mar 2003 | A1 |
20030064507 | Gallagher et al. | Apr 2003 | A1 |
20030070677 | Handique et al. | Apr 2003 | A1 |
20030073106 | Johansen et al. | Apr 2003 | A1 |
20030083686 | Freeman et al. | May 2003 | A1 |
20030087300 | Knapp et al. | May 2003 | A1 |
20030096310 | Hansen et al. | May 2003 | A1 |
20030127327 | Kurnik | Jul 2003 | A1 |
20030136679 | Bohn et al. | Jul 2003 | A1 |
20030186295 | Colin et al. | Oct 2003 | A1 |
20030190608 | Blackburn | Oct 2003 | A1 |
20030199081 | Wilding et al. | Oct 2003 | A1 |
20030211517 | Carulli et al. | Nov 2003 | A1 |
20040014238 | Krug et al. | Jan 2004 | A1 |
20040029258 | Heaney et al. | Feb 2004 | A1 |
20040029260 | Hansen et al. | Feb 2004 | A1 |
20040037739 | McNeely et al. | Feb 2004 | A1 |
20040053290 | Terbrueggen et al. | Mar 2004 | A1 |
20040063217 | Webster et al. | Apr 2004 | A1 |
20040072278 | Chou et al. | Apr 2004 | A1 |
20040072375 | Gjerde et al. | Apr 2004 | A1 |
20040086956 | Bachur | May 2004 | A1 |
20040141887 | Mainquist et al. | Jul 2004 | A1 |
20040151629 | Pease et al. | Aug 2004 | A1 |
20040157220 | Kurnool et al. | Aug 2004 | A1 |
20040161788 | Chen et al. | Aug 2004 | A1 |
20040189311 | Glezer et al. | Sep 2004 | A1 |
20040200909 | McMillan et al. | Oct 2004 | A1 |
20040209331 | Ririe | Oct 2004 | A1 |
20040209354 | Mathies et al. | Oct 2004 | A1 |
20040219070 | Handique | Nov 2004 | A1 |
20040235154 | Oh et al. | Nov 2004 | A1 |
20040240097 | Evans | Dec 2004 | A1 |
20050009174 | Nikiforov et al. | Jan 2005 | A1 |
20050041525 | Pugia et al. | Feb 2005 | A1 |
20050042639 | Knapp et al. | Feb 2005 | A1 |
20050048540 | Inami et al. | Mar 2005 | A1 |
20050058574 | Bysouth et al. | Mar 2005 | A1 |
20050084424 | Ganesan et al. | Apr 2005 | A1 |
20050106066 | Saltsman et al. | May 2005 | A1 |
20050121324 | Park et al. | Jun 2005 | A1 |
20050129580 | Swinehart et al. | Jun 2005 | A1 |
20050133370 | Park et al. | Jun 2005 | A1 |
20050135655 | Kopf-Sill et al. | Jun 2005 | A1 |
20050152808 | Ganesan | Jul 2005 | A1 |
20050170362 | Wada et al. | Aug 2005 | A1 |
20050186585 | Juncosa et al. | Aug 2005 | A1 |
20050202470 | Sundberg et al. | Sep 2005 | A1 |
20050202504 | Anderson et al. | Sep 2005 | A1 |
20050208676 | Kahatt | Sep 2005 | A1 |
20050220675 | Reed et al. | Oct 2005 | A1 |
20050227269 | Lloyd et al. | Oct 2005 | A1 |
20050233370 | Ammann et al. | Oct 2005 | A1 |
20050238545 | Parce et al. | Oct 2005 | A1 |
20050272079 | Burns et al. | Dec 2005 | A1 |
20060041058 | Yin et al. | Feb 2006 | A1 |
20060057039 | Morse et al. | Mar 2006 | A1 |
20060057629 | Kim | Mar 2006 | A1 |
20060062696 | Chow et al. | Mar 2006 | A1 |
20060094108 | Yoder et al. | May 2006 | A1 |
20060113190 | Kurnik | Jun 2006 | A1 |
20060133965 | Tajima et al. | Jun 2006 | A1 |
20060134790 | Tanaka et al. | Jun 2006 | A1 |
20060148063 | Fauzzi et al. | Jul 2006 | A1 |
20060165558 | Witty et al. | Jul 2006 | A1 |
20060165559 | Greenstein et al. | Jul 2006 | A1 |
20060166233 | Wu et al. | Jul 2006 | A1 |
20060177376 | Tomalia et al. | Aug 2006 | A1 |
20060177855 | Utermohlen et al. | Aug 2006 | A1 |
20060183216 | Handique et al. | Aug 2006 | A1 |
20060207944 | Siddiqi | Sep 2006 | A1 |
20060210435 | Alavie et al. | Sep 2006 | A1 |
20060246493 | Jensen et al. | Nov 2006 | A1 |
20060246533 | Fathollahi et al. | Nov 2006 | A1 |
20070004028 | Lair et al. | Jan 2007 | A1 |
20070009386 | Padmanabhan et al. | Jan 2007 | A1 |
20070020699 | Carpenter et al. | Jan 2007 | A1 |
20070026421 | Sundberg et al. | Feb 2007 | A1 |
20070042441 | Masters et al. | Feb 2007 | A1 |
20070092901 | Ligler et al. | Apr 2007 | A1 |
20070098600 | Kayyem et al. | May 2007 | A1 |
20070099200 | Chow et al. | May 2007 | A1 |
20070104617 | Coulling et al. | May 2007 | A1 |
20070154895 | Spaid et al. | Jul 2007 | A1 |
20070177147 | Parce | Aug 2007 | A1 |
20070178607 | Prober et al. | Aug 2007 | A1 |
20070184463 | Molho et al. | Aug 2007 | A1 |
20070184547 | Handique et al. | Aug 2007 | A1 |
20070196238 | Kennedy et al. | Aug 2007 | A1 |
20070199821 | Chow | Aug 2007 | A1 |
20070215554 | Kreuwel et al. | Sep 2007 | A1 |
20070218459 | Miller et al. | Sep 2007 | A1 |
20070231213 | Prabhu et al. | Oct 2007 | A1 |
20070243626 | Windeyer et al. | Oct 2007 | A1 |
20070261479 | Spaid et al. | Nov 2007 | A1 |
20070269861 | Williams et al. | Nov 2007 | A1 |
20070292941 | Handique et al. | Dec 2007 | A1 |
20080000774 | Park et al. | Jan 2008 | A1 |
20080017306 | Liu et al. | Jan 2008 | A1 |
20080050804 | Handique et al. | Feb 2008 | A1 |
20080056948 | Dale et al. | Mar 2008 | A1 |
20080069729 | McNeely | Mar 2008 | A1 |
20080075634 | Herchenbach et al. | Mar 2008 | A1 |
20080090244 | Knapp et al. | Apr 2008 | A1 |
20080095673 | Xu | Apr 2008 | A1 |
20080118987 | Eastwood et al. | May 2008 | A1 |
20080124723 | Dale et al. | May 2008 | A1 |
20080149840 | Handique et al. | Jun 2008 | A1 |
20080160601 | Handique | Jul 2008 | A1 |
20080182301 | Handique et al. | Jul 2008 | A1 |
20080192254 | Kim et al. | Aug 2008 | A1 |
20080226502 | Jonsmann et al. | Sep 2008 | A1 |
20080247914 | Edens et al. | Oct 2008 | A1 |
20080262213 | Wu et al. | Oct 2008 | A1 |
20090047713 | Handique | Feb 2009 | A1 |
20090129978 | Wilson et al. | May 2009 | A1 |
20090130719 | Handique | May 2009 | A1 |
20090130745 | Williams et al. | May 2009 | A1 |
20090131650 | Brahmasandra et al. | May 2009 | A1 |
20090134069 | Handique | May 2009 | A1 |
20090136385 | Handique et al. | May 2009 | A1 |
20090136386 | Duffy et al. | May 2009 | A1 |
20090155123 | Williams et al. | Jun 2009 | A1 |
20090189089 | Bedingham et al. | Jul 2009 | A1 |
20090221059 | Williams et al. | Sep 2009 | A1 |
20090223925 | Morse et al. | Sep 2009 | A1 |
20100009351 | Brahmasandra et al. | Jan 2010 | A1 |
20100173393 | Handique et al. | Jul 2010 | A1 |
20110008825 | Ingber et al. | Jan 2011 | A1 |
20110027151 | Handique et al. | Feb 2011 | A1 |
20110207140 | Handique et al. | Aug 2011 | A1 |
20110210257 | Handique et al. | Sep 2011 | A9 |
20120022695 | Handique et al. | Jan 2012 | A1 |
20120085416 | Ganesan | Apr 2012 | A1 |
20120122108 | Handique | May 2012 | A1 |
20120160826 | Handique | Jun 2012 | A1 |
20120171759 | Williams et al. | Jul 2012 | A1 |
20120183454 | Handique | Jul 2012 | A1 |
20120258463 | Duffy et al. | Oct 2012 | A1 |
20130037564 | Williams et al. | Feb 2013 | A1 |
20130101990 | Handique et al. | Apr 2013 | A1 |
20130164832 | Ganesan | Jun 2013 | A1 |
Number | Date | Country |
---|---|---|
2294819 | Jan 1999 | CA |
19929734 | Dec 1999 | DE |
0766256 | Apr 1997 | EP |
2372367 | Oct 2011 | EP |
2672301 | Aug 1992 | FR |
2795426 | Dec 2000 | FR |
58212921 | Dec 1983 | JP |
H07-290706 | Nov 1995 | JP |
2001-502790 | Jan 1998 | JP |
2000-514928 | Apr 1999 | JP |
2001-509437 | Jul 2001 | JP |
2001-515216 | Sep 2001 | JP |
2001-527220 | Dec 2001 | JP |
2002-215241 | Jul 2002 | JP |
2003-500674 | Jan 2003 | JP |
2005-514718 | May 2005 | JP |
2005-204661 | Aug 2005 | JP |
2005-291954 | Oct 2005 | JP |
WO 8806633 | Sep 1988 | WO |
WO 9012350 | Oct 1990 | WO |
WO 9205443 | Apr 1992 | WO |
WO 9705492 | Feb 1997 | WO |
WO 9800231 | Jan 1998 | WO |
WO 9822625 | May 1998 | WO |
WO 9853311 | Nov 1998 | WO |
WO 9901688 | Jan 1999 | WO |
WO 9909042 | Feb 1999 | WO |
WO 9912016 | Mar 1999 | WO |
WO 9933559 | Jul 1999 | WO |
WO 0105510 | Jan 2001 | WO |
WO 0114931 | Mar 2001 | WO |
WO 0127614 | Apr 2001 | WO |
WO 0128684 | Apr 2001 | WO |
WO 0141931 | Jun 2001 | WO |
WO 0154813 | Aug 2001 | WO |
WO 0189681 | Nov 2001 | WO |
WO 02072264 | Sep 2002 | WO |
WO 02078845 | Oct 2002 | WO |
WO 03012325 | Feb 2003 | WO |
WO 03012406 | Feb 2003 | WO |
WO 03048295 | Jun 2003 | WO |
WO 03055605 | Jul 2003 | WO |
WO 2004007081 | Jan 2004 | WO |
WO 2004055522 | Jul 2004 | WO |
WO 2004074848 | Sep 2004 | WO |
WO 2005011867 | Feb 2005 | WO |
WO 2005108620 | Nov 2005 | WO |
WO 2006079082 | Jul 2006 | WO |
WO 2007044917 | Apr 2007 | WO |
WO 2007050327 | May 2007 | WO |
WO 2008030914 | Mar 2008 | WO |
WO 2008060604 | May 2008 | WO |
WO 2009012185 | Jan 2009 | WO |
WO 2010118541 | Oct 2010 | WO |
Entry |
---|
Bollet, C. et al., “A simple method for the isolation of chromosomal DNA from Gram positive or acid-fast bacteria”, Nucleic Acids Research, vol. 19, No. 8 (1991), p. 1955. |
Brahmassandra, et al., On-Chip DNA Detection in Microfabricated Separation Systems, Part of the SPIE Conference on Microfluidic Devices and Systems, 1998, Santa Clara, California, vol. 3515, pp. 242-251. |
Breadmore, M.C. et al., “Microchip-Based Purification of DNA from Biological Samples”, Anal. Chem., vol. 75 (2003), pp. 1880-1886. |
Brody, et al., Diffusion-Based Extraction in a Microfabricated Device, Sensors and Actuators Elsevier, 1997, vol. A58, No. 1, pp. 13-18. |
Broyles et al., “Sample Filtration, Concentration, and Separation Integrated on Microfluidic Devices” Analytical Chemistry (American Chemical Society), (2003) 75(11): 2761-2767. |
Burns et al., “An Integrated Nanoliter DNA Analysis Device”, Science 282:484-487 (1998). |
Carlen et al., “Paraffin Actuated Surface Micromachined Valve,” in IEEE MEMS 2000 Conference, Miyazaki, Japan, (Jan. 2000) pp. 381-385. |
Chung, Y. et al., “Microfluidic chip for high efficiency DNA extraction”, Miniaturisation for Chemistry, Biology & Bioengineering, vol. 4, No. 2 (Apr. 2004), pp. 141-147. |
File History of the related U.S. Appl. No. 11/281,247, as of Jun. 1, 2010. |
Handique K., et al., On-Chip Thermopneumatic Pressure for Discrete Drop Pumping, Analytical Chemistry, American Chemical Society, Apr. 15, 2001, vol. 73, No. 8, 1831-1838. |
Handique, K. et al, “Microfluidic flow control using selective hydrophobic patterning”, SPIE, vol. 3224, pp. 185-194 (1997). |
Handique, K. et al., “Nanoliter-volume discrete drop injection and pumping in microfabricated chemical analysis systems”, Solid-State Sensor and Actuator Workshop (Hilton Head, South Carolina, Jun. 8-11, 1998) pp. 346-349. |
Handique, K. et al., “Mathematical Modeling of Drop Mixing in a Slit-Type Microchannel”, J. Micromech. Microeng., 11:548-554 (2001). |
Handique, K. et al., “Nanoliter Liquid Metering in Microchannels Using Hydrophobic Patterns”, Anal. Chem., 72:4100-4109 (2000). |
He, et al., Microfabricated Filters for Microfluidic Analytical Systems, Analytical Chemistry, American Chemical Society, 1999, vol. 71, No. 7, pp. 1464-1468. |
Ibrahim, et al., Real-Time Microchip PCR for Detecting Single-Base Differences in Viral and Human DNA, Analytical Chemistry, American Chemical Society, 1998, vol. 70, No. 9, pp. 2013-2017. |
Khandurina, et al., Microfabricated Porous Membrane Structure for Sample Concentration and Electrophoretic Analysis, Analytical Chemistry American Chemical Society, 1999, vol. 71, No. 9, pp. 1815-1819. |
Kopp, et al., Chemical Amplification: Continuous-Flow PCR on a Chip, www.sciencemag.org, 1998, vol. 280, pp. 1046-1048. |
Kutter, et al., Solid Phase Extraction on Microfluidic Devices, J. Microcolumn Separations, John Wiley & Sons, Inc., 2000, vol. 12, No. 2, pp. 93-97. |
Lagally, et al., Single-Molecule DNA Amplification and Analysis in an Integrated Microfluidic Device, Analytical Chemistry, American Chemical Society, 2001, vol. 73, No. 3 pp. 565-570. |
Livache, T. et al., “Polypyrrole DNA chip on a Silicon Device: Example of Hepatitis C Virus Genotyping”, Analytical Biochemistry, vol. 255 (1998), pp. 188-194. |
Northrup, et al., A Miniature Analytical Instrument for Nucleic Acids Based on Micromachined Silicon Reaction Chambers, Analytical Chemistry, American Chemical Society, 1998, vol. 70, No. 5, pp. 918-922. |
Oleschuk, et al., Trapping of Bead-Based Reagents within Microfluidic Systems,: On-Chip Solid-Phase Extraction and Electrochromatography, Analytical Chemistry, American Chemical Society, 2000, vol. 72, No. 3, pp. 585-590. |
Roche, et al. “Ectodermal commitment of insulin-producing cells derived from mouse embryonic stem cells” Faseb J (2005) 19: 1341-1343. |
Ross, et al., Analysis of DNA Fragments from Conventional and Microfabricated PCR Devices Using Delayed Extraction MALDI-TOF Mass Spectrometry, Analytical Chemistry, American Chemical Society, 1998, vol. 70, No. 10, pp. 2067-2073. |
Shoffner, M. A. et al., Chip PCR.I. Surface Passivation of Microfabricated Silicon-Glass Chips for PCR, Nucleic Acids Research, Oxford University Press, 1996, vol. 24, No. 2, 375-379. |
Smith, K. et al., “Comparison of Commercial DNA Extraction Kits for Extraction of Bacterial Genomic DNA from Whole-Blood Samples”, Journal of Clinical Microbiology, vol. 41, No. 6 (Jun. 2003), pp. 2440-2443. |
Waters, et al., Microchip Device for Cell Lysis, Multiplex PCR Amplification, and Electrophoretic Sizing, Analytical Chemistry, American Chemical Society, 1998, vol. 70, No. 1, pp. 158-162. |
Weigl, et al., Microfluidic Diffusion-Based Separation and Detection, www.sciencemag.org, 1999, vol. 283, pp. 346-347. |
Yoza et al., DNA extraction using bacterial magnetic particles modified with hyperbranched polyamidoamine dendrimer, Mar. 20, 2003, vol. 101, No. 3, 219-228. |
Yoza et al., “Fully Automated DNA Extraction from Blood Using Magnetic Particles Modified with a Hyperbranched Polyamidomine Dendrimer”, Journal of Bioscience and Bioengineering, 95(1):21-26, 2003. |
Mascini et al., “DNA electrochemical biosensors”, Fresenius J. Anal. Chem., 369: 15-22, (2001). |
Nakagawa et al., Fabrication of amino silane-coated microchip for DNA extraction from whole blood, J of Biotechnology, Mar. 2, 2005, vol. 116, pp. 105-111. |
Plambeck et al., “Electrochemical Studies of Antitumor Antibiotics”, J. Electrochem Soc.: Electrochemical Science and Technology (1984), 131(11): 2556-2563. |
Wang, “Survey and Summary, from DNA Biosensors to Gene Chips”, Nucleic Acids Research, 28(16):3011-3016, (2000). |
International Search Report dated Sep. 23, 2002 for Application No. PCT/US2002/009441, filed Mar. 27, 2002. |
International Preliminary Examination Report dated Dec. 17, 2003 for Application No. PCT/US2002/009441, filed Mar. 27, 2002. |
Supplementary European Search Report dated Jun. 3, 2005 for European Patent Application No. 02723636.3, filed Mar. 27, 2002. |
EP Communication dated Aug. 9, 2006 for European Patent Application 02723636.3. |
Number | Date | Country | |
---|---|---|---|
20130071851 A1 | Mar 2013 | US |
Number | Date | Country | |
---|---|---|---|
60307638 | Jul 2001 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11929971 | Oct 2007 | US |
Child | 13620452 | US | |
Parent | 10075371 | Feb 2002 | US |
Child | 11929971 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10014519 | Dec 2001 | US |
Child | 10075371 | US | |
Parent | 09953921 | Sep 2001 | US |
Child | 10014519 | US | |
Parent | 09819105 | Mar 2001 | US |
Child | 09953921 | US |